The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women A cost-utility analysis. - Doiron, R. Christopher; Nickel, J. Curtis; Kamdar, Shivani (Canadian Urological Association Journal, 2026)